A Blog by AMCP CEO Susan Cantrell


AMCP_Beyond 
 

 


AMCP Nexus 2017 Theme Announced: “Changing the Way We Pay for Health Care”

 

 Blog Photo 05-02-17 
 

May 2, 2017 

Volume to value, quantity to quality: such transitions in health care today are like a rock tossed in a pond. The ripple effects are far-reaching and unstoppable. So important is this transformation that we’re dedicating a significant amount of programming to the topic at our fall conference in Dallas (Oct. 16-19). In fact, we’re calling it “AMCP Nexus 2017: Changing the Way We Pay for Health Care.”

Looking back, we’ve come a long way in just a relatively short amount of time. A decade ago, the idea of linking the cost of a therapy to how well it performed was considered revolutionary. Today, value-based contracting models increasingly are considered to manage escalating health care expenditures.

I’m pleased to say that AMCP is helping usher in this new era of value-based contracting. In the coming months, we will be fully engaged in various activities that explore the promises and challenges of paying for products based on how well they perform.

Stakeholders are looking for new models that reward and incentivize value, most notably through novel arrangements around the pricing and reimbursement of biopharmaceuticals. In one model known as outcomes-based pricing, payers and patients would receive a rebate from a manufacturer if its product failed to work. Another model known as value-based purchasing involves negotiating prices based on a clearer understanding of health care economic data behind the product.

Such value-based models require stakeholder agreement on how a drug is assessed in the real world. That is where managed care pharmacy comes into play.

AMCP’s leadership efforts in this area include the introduction last month of the "Pharmaceutical Information Exchange (PIE) Act of 2017" (HR 2026). The bill clarifies the scope of health care economic and scientific information that may be shared between biopharmaceutical manufacturers and population health decision makers in advance of product approval. The PIE Act would allow payers and manufacturers to share more data and information when negotiating contracts, a necessary condition for value-based purchasing.

AMCP’s leadership also can be seen in its plans for a June partnership forum on the nitty-gritty practicalities of implementing value-based contracting. The diverse stakeholders will seek consensus on a definition of value-based contracting to help facilitate discussions with key policy-makers and regulators. They also will develop action plans to mitigate legal and regulatory barriers to value-based contracting, and identify ways to improve operational challenges related to data validation, integration, and methodologies.

And AMCP’s leadership will continue at AMCP Nexus 2017 in October. The conference will include specific programming on new and emerging reimbursement and value-based models, as well as General Session that spotlights the nation’s leading lights in this topic. Watch for more details later this month when our meeting website launches. Registration opens June 20 at 1pm Eastern!

Changing the way we pay for health care! It’s coming, it will be based on value, and AMCP will be leading the way.


Susan A. Cantrell, RPh, CAE is CEO of the Academy of Managed Care Pharmacy 


 


Eye on the Hill: AMCP Sees Progress in PIE Bill and Will Continue to Promote Comprehensive Pharmacy Benefit in Health Care Reform Efforts

 

April 11, 2017 

Whoever said, “May you live in interesting times,” could have been talking about Congressional health care policy debates circa 2017. Never a dull moment!

Many things are happening on the health care legislative front, and AMCP has been in the thick of it. ... Read more.


 


AMCP Celebrates Early Win: FDA Issues Draft Guidance to Improve Communications Between Biopharmaceutical Companies and Population Health Decision Makers

 

March 1, 2017 

Every morning — like many of you — I settle behind my desk, take a sip of coffee and read the AMCP Daily Dose. This publication, full of valuable news and information, frequently highlights issues and individuals we’re featuring at our Annual Meeting, March 27-30, in Denver. Several caught my eye recently. ... Read more.


 


AMCP Celebrates Early Win: FDA Issues Draft Guidance to Improve Communications Between Biopharmaceutical Companies and Population Health Decision Makers

 

February 1, 2017 

Sometimes the best laid plans are upended when you least expect it!

In mid-January, the FDA released draft guidance to facilitate the sharing of information between biopharmaceutical companies and population health decision makers. To say we were pleasantly surprised is an understatement. ... Read more.


 


Making PIE to Better Serve Patients

 

January 11, 2017 

Let’s imagine you’re a big city mayor and it’s time to order a new fleet of police cars for next year. Applying due diligence, you set out to compare various models from a variety of manufacturers. ... Read more.


 


Century Cures Act Advances AMCP's FDAMA Goals, Improves Value-Based Communications Between Manufacturers and Managed Care Pharmacy

 

December 22, 2016 

Who says Congress can’t get anything done…and with bipartisan support to boot? With impressive speed and purpose, the House and Senate overwhelmingly passed the 21st Century Cures Act in the waning days of the 114th Congress, followed by President Obama’s prompt signature. ... Read more.


 


Pharmacy Profession Comes Together to Help Document and Improve Patient Outcomes Through Medication Therapy Management

 

November 7, 2016 

People can accomplish remarkable things when they work toward a common goal. That’s what happened recently when a diverse group of pharmacy stakeholders gathered to develop standardized terms for medication therapy management (MTM) services. ... Read more.


 


AMCP really knows how to get things done!

 

October 13, 2016 

Not long ago a respected individual in the health care arena told one of my senior staff: “Compared to other associations I work with, AMCP really knows how to get things done.” You cannot imagine how proud I felt ... Read more.


 


AMCP Volunteers Are a Happy Lot

 

September 20, 2016 

There are many ways to measure the health and vitality of a professional association. The most crucial indicators, I’ve found, center on the engagement of an organization’s volunteers. This can be measured in the number of volunteer opportunities provided, the number of members who sign up, and the level of satisfaction they get from volunteering. ... Read more.


 


The Post Cites Pharmacists’ Expanding Role on Medical Teams

 

August 26, 2016 

Last week I saw a headline that jumped off the page: “America’s other drug problem: Giving the elderly too many prescriptions” (Washington Post, Aug. 15). I couldn’t read it fast enough and encourage members to do likewise, as it highlights two of the most important developments in health care. ... Read more.


 


Seizing Opportunity: AMCP Nexus 2016 Offers Knowledge, Advancement and More

 

August 3, 2016 

“Healing is a matter of time, but it is sometimes also a matter of opportunity,” said the great Hippocrates, father of western medicine.

Opportunity, in fact, is a crucial element in the work that managed care pharmacy professionals engage in every day to improve the health, wellbeing and “healing” of millions of patients. We seize opportunities to find the right medicines for the right patients at the right time. ... Read more.


 


BRC Now Lets You Look It Up

 

July 13, 2016 

It was only ten years ago when biosimilars were so new that the New York Times described them as “so-called.” As late as five years ago newspapers put quotation marks around the term, as in “biosimilars.” At the time some still called them “follow-on” biopharmaceutics. ... Read more.


 


Is FDAMA Section 114 Finally Ready for Prime Time?

 

June 24, 2016 

Information is the life blood of managed care pharmacy. Of the “competent and reliable scientific” variety, that is.

Our profession operates best when we have broad access to the latest evidence-based data on the multitude of products coming to market today. We can plan, we can assess. With this information, managed care pharmacy professionals can help health care providers and patients select the right drug for the right patient at the right time, while making appropriate use of our scarce health care dollars. ... Read more.


 


Getting it straight with the updated AMCP Format!

 

May 19, 2016 

Using the best evidence possible to make informed health care decisions is a hallmark of managed care pharmacy. But making sense of the data often is no easy task, especially when it comes to analyzing pharmaceuticals and the value they bring to patients and the health care system... Read more.


 


CEO Susan Cantrell Addresses AMCP Annual Meeting

 

May 10, 2016 

New&Views announces a new monthly column by CEO Susan A. Cantrell, RPh, CAE, on breaking news and critical issues. Her first column presents her recent address―her first to the membership―at AMCP’s recent Annual Meeting.

“It is truly an honor to be standing before you today as the Academy’s new CEO. While new to the AMCP staff, I’ve been an observer and at times a participant in the terrific work of this organization. ..." Read more.